$394.53
-2.84-0.71%
In chiusura: -
$392.53
-2.00-0.51%
After hour: 4:01 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Vertex Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 3
Stima EPS
$4.370
Stima dei ricavi trimestrali
$3.05B
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$11.42B
Analizza lo storico degli utili di Vertex Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX | Vertex Pharmaceuticals | $4.38 | $4.37 | — | — | $2.77B | $3.05B | — | — | 11/03/2025 | |
VRTX | Vertex Pharmaceuticals | -$12.83 | $4.05 | $4.52 | 11.88% | $2.65B | $2.90B | $2.96B | 2.24% | 08/04/2025 | |
VRTX | Vertex Pharmaceuticals | $4.76 | $4.29 | $4.06 | -5.36% | $2.69B | $2.86B | $2.77B | -3.15% | 05/05/2025 | |
VRTX | Vertex Pharmaceuticals | $4.20 | $4.02 | $3.98 | -1.00% | $2.52B | $2.78B | $2.91B | 4.75% | 02/10/2025 | |
VRTX | Vertex Pharmaceuticals | $4.08 | $4.14 | $4.38 | 5.80% | $2.48B | $2.72B | $2.77B | 1.91% | 11/04/2024 | |
VRTX | Vertex Pharmaceuticals | $3.89 | $4.14 | -$12.83 | -409.90% | $2.49B | $2.66B | $2.65B | -0.53% | 08/01/2024 | |
VRTX | Vertex Pharmaceuticals | $3.05 | $4.02 | $4.76 | 18.41% | $2.38B | $2.57B | $2.69B | 4.67% | 05/06/2024 | |
VRTX | Vertex Pharmaceuticals | $3.76 | $4.10 | $4.20 | 2.44% | $2.30B | $2.51B | $2.52B | 0.31% | 02/05/2024 | |
VRTX | Vertex Pharmaceuticals | $4.01 | $3.98 | $4.08 | 2.51% | $2.33B | $2.50B | $2.48B | -0.64% | 11/06/2023 | |
VRTX | Vertex Pharmaceuticals | $3.60 | $3.85 | $3.89 | 1.04% | $2.20B | $2.41B | $2.49B | 3.44% | 08/01/2023 | |
VRTX | Vertex Pharmaceuticals | $3.52 | $3.00 | $3.05 | 1.67% | $2.10B | $2.34B | $2.38B | 1.50% | 05/01/2023 | |
VRTX | Vertex Pharmaceuticals | $3.37 | $3.51 | $3.76 | 7.12% | $2.07B | $2.30B | $2.30B | 0.13% | 02/07/2023 | |
VRTX | Vertex Pharmaceuticals | $3.56 | $3.67 | $4.01 | 9.26% | $1.98B | $2.23B | $2.33B | 4.66% | 10/27/2022 | |
VRTX | Vertex Pharmaceuticals | $3.11 | $3.52 | $3.60 | 2.27% | $1.79B | $2.13B | $2.20B | 3.10% | 08/04/2022 | |
VRTX | Vertex Pharmaceuticals | $2.98 | $3.49 | $3.52 | 0.86% | $1.72B | $2.08B | $2.10B | 0.82% | 05/05/2022 | |
VRTX | Vertex Pharmaceuticals | $2.51 | $3.29 | $3.37 | 2.43% | $1.63B | $2.00B | $2.07B | 3.65% | 01/26/2022 | |
VRTX | Vertex Pharmaceuticals | $2.64 | $3.08 | $3.56 | 15.58% | $1.54B | $1.86B | $1.98B | 6.67% | 11/02/2021 | |
VRTX | Vertex Pharmaceuticals | $2.61 | $2.28 | $3.11 | 36.40% | $1.52B | $1.72B | $1.79B | 4.24% | 07/29/2021 | |
VRTX | Vertex Pharmaceuticals | $2.56 | $2.69 | $2.98 | 10.78% | $1.51B | $1.66B | $1.72B | 3.86% | 04/29/2021 | |
VRTX | Vertex Pharmaceuticals | $1.70 | $2.59 | $2.51 | -3.09% | $1.26B | $1.58B | $1.63B | 3.04% | 02/01/2021 | |
VRTX | Vertex Pharmaceuticals | $1.23 | $2.32 | $2.64 | 13.79% | $949.83M | $1.47B | $1.54B | 4.63% | 10/29/2020 |
Vertex Pharmaceuticals (VRTX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-04 | $4.52 | $4.05 | 11.9 % |
| Q1 | 2025-05-05 | $4.06 | $4.29 | -5.36 % |
| Q4 | 2025-02-10 | $3.98 | $4.02 | -1.00 % |
| Q3 | 2024-11-04 | $4.38 | $4.14 | 5.80 % |
Vertex Pharmaceuticals (VRTX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-04 | $2.97B | $2.90B | 2.24 % |
| Q1 | 2025-05-05 | $2.77B | $2.86B | -3.15 % |
| Q4 | 2025-02-10 | $2.91B | $2.78B | 4.75 % |
| Q3 | 2024-11-04 | $2.77B | $2.72B | 1.91 % |
FAQ
Quando Vertex Pharmaceuticals (NASDAQ:VRTX) riporterà gli utili?
Si prevede che Vertex Pharmaceuticals (VRTX) fornisca risultati il novembre 3, 2025. Gli ultimi risultati sono stati pubblicati il agosto 4, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Vertex Pharmaceuticals (NASDAQ:VRTX)?
L'EPS effettivo era $4.52, che superato la stima di $4.05.
Quali sono state le entrate di Vertex Pharmaceuticals (NASDAQ:VRTX)?
Le entrate effettive sono state $3B, che superato la stima di $2.9B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.